EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing

Zakir Khan iD, Frank Moriarty iD

Clinical Pharmacology & Therapeutics · 2026-09 · 120 (3) · 663-666

DOI: 10.1002/cpt.70356 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 06.06.2026. Verfasst von Zakir Khan und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Deprescriptions, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacovigilance plays a crucial role in post‐marketing surveillance of medicines and relies on the spontaneous reporting of adverse drug reactions (ADRs). Discontinuation of a drug can cause clinically relevant signs and symptoms, including withdrawal reactions; however, this subset of ADRs is not fully accommodated in current pharmacovigilance practice. We discuss proposed revisions to current ADR forms that could enhance the capture of withdrawal reaction evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDeprescriptionsDrug-Related Side Effects and Adverse ReactionsHumansProduct Surveillance, Postmarketing

Autor:innen und Institutionen

  • School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

ORCID-Profile: Zakir Khan, Frank Moriarty

Zitieren

APA

Khan, Z., & Moriarty, F. (2026). Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing. Clinical Pharmacology & Therapeutics, 120(3), 663-666. https://doi.org/10.1002/cpt.70356

Vancouver

Khan Z, Moriarty F. Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing. Clinical Pharmacology & Therapeutics. 2026;120(3):663-666. doi:10.1002/cpt.70356

BibTeX
@article{Khan2026,
  author = {Khan, Zakir and Moriarty, Frank},
  title = {Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  volume = {120},
  number = {3},
  pages = {663--666},
  doi = {10.1002/cpt.70356}
}
Kostenlos starten →